首页> 外文期刊>Trends in Ecology & Evolution >ECPELLA 2.0-Minimally invasive biventricular groin-free full mechanical circulatory support with Impella 5.0/5.5 pump and ProtekDuo cannula as a bridge-to-bridge concept: A first-in-man method description
【24h】

ECPELLA 2.0-Minimally invasive biventricular groin-free full mechanical circulatory support with Impella 5.0/5.5 pump and ProtekDuo cannula as a bridge-to-bridge concept: A first-in-man method description

机译:ecpella 2.0-微创的自动侵入性腹股沟无腹股沟完全机械循环支撑,带有偶像5.0 / 5.5泵和Protekduo Cannula作为桥接到桥梁概念:一个先进的方法描述

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Cardiogenic shock (CS) from biventricular heart failure that requires acute mechanical circulatory support (MCS) is associated with high mortality. Different MCS methods and techniques have emerged as a standard of care in CS. Nevertheless, the routine MCS approach carries multiple limitations such as limb ischemia, missing of left ventricular unloading and immobilization. We describe a method to establish a groin-free full support MCS in patients with CS without the need for thoracotomy. This is the first report of the ECPELLA 2.0 concept, a peripheral groin-free biventricular MCS in patients with acute CS. Methods and results We discuss two patients in acute CS (INTERMACS I) treated with two peripheral MCS devices (Impella 5.0 or 5.5 surgically via an axillary artery and ProtekDuo cannula percutaneously via a right internal jugular vein) as a bridge before the implantation of a durable left ventricular assist device (LVAD). Biventricular assist device (BIVAD)-support duration was 9 and 15 days and both of the patients were successfully bridged to a durable LVAD. As our BIVAD-concept is groin-free, the patients started full mobilization as early as they were weaned from the respirator 2 days after the BIVAD-implantation. ECPELLA 2.0 provides a high cardiac output, right and left ventricular unloading with end-organ recovery and a possibility of administration of a membrane oxygenator. There were no device-related complications. Conclusion The ECPELLA 2.0 biventricular support concept for patients suffering from an acute CS. Allows for rapid extubation, mobilization, and physical exercise while on full support. Additional application of a membrane oxygenator is easily feasible if required.
机译:背景技术需要急性机械循环载体(MCS)的五年前心脏衰竭的心源性休克(CS)与高死亡率有关。不同的MCS方法和技术已成为CS中的护理标准。然而,常规MCS方法具有多种限制,例如肢体缺血,缺少左心室卸载和固定。我们描述了一种在CS患者中建立无腹股沟的完全支持MCS的方法,而无需胸廓切开术。这是Ecpella 2.0概念的第一个报告,急性Cs患者的外周腹股沟生物MCS。方法和结果我们讨论用两个外周MCS器件(Impella 5.0或5.5通过腋动脉和Protekduo Cannula通过右内部颈静脉通过腋动脉和Protekduo Cannula手术进行手术处理的急性Cs(Intermaces I)中的两名患者,作为植入耐用的桥梁左心室辅助装置(LVAD)。五年级辅助装置(Bivad)-Support持续时间为9岁,15天,两位患者都成功地桥接到耐用的LVAD。由于我们的Bivad-Concept是无螺洞,患者早期开始全动员,因为双抗体植入后2天后从呼吸器断奶。 ECPella 2.0提供高心输出,右和左心室卸载,末端器官回收和施用膜氧的可能性。没有与设备相关的并发症。结论ECPella 2.0患有急性Cs的患者的五级别支持概念。在全面支持时允许快速拔管,动员和体育锻炼。如果需要,膜氧吸附剂的额外施用易于可行。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号